Myriad Genetics MYGN reported its Q3 earnings results on Tuesday, November 1, 2022 at 09:05 AM.
Here's what investors need to know about the announcement.
Myriad Genetics missed estimated earnings by 216.67%, reporting an EPS of $-0.19 versus an estimate of $-0.06.
Revenue was down $10.90 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 0.22% increase in the share price the next day.
Here's a look at Myriad Genetics's past performance:
|Quarter||Q2 2022||Q1 2022||Q4 2021||Q3 2021|
To track all earnings releases for Myriad Genetics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.